Trinity Biotech Plc (TRIB)
0.68
+0.01
(+1.87%)
USD |
NASDAQ |
Jun 08, 16:00
0.68
0.00 (0.00%)
After-Hours: 18:38
Trinity Biotech EPS Diluted (Quarterly) : -0.9375 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amarin Corp. Plc | -0.501 |
| Grifols SA | 0.1255 |
| Cellectis SA | -0.1774 |
| Akari Therapeutics Plc | -9.584 |
| Autolus Therapeutics Plc | -0.2686 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.46M |
| Revenue (Quarterly) | 11.06M |
| Total Expenses (Quarterly) | 28.53M |
| Enterprise Value | 145.75M |
| Gross Profit Margin (Quarterly) | 32.05% |
| Profit Margin (Quarterly) | -157.8% |
| Earnings Yield | -296.6% |
| Normalized Earnings Yield | -260.91 |